Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 227

    1.

    Arrhythmias in patients with chronic obstructive pulmonary disease (COPD): occurrence frequency and the effect of treatment with the inhaled long-acting beta2-agonists arformoterol and salmeterol.

    Hanrahan JP, Grogan DR, Baumgartner RA, Wilson A, Cheng H, Zimetbaum PJ, Morganroth J.

    Medicine (Baltimore). 2008 Nov;87(6):319-28.PMID: 19011503 [PubMed - indexed for MEDLINE]Related articles

    2.

    Proarrhythmic potential of reverse use-dependent drugs.

    Gussak I, Litwin J, Morganroth J.

    J Electrocardiol. 2007 Sep-Oct;40(5):432-3. Epub 2007 May 24. No abstract available. PMID: 17531256 [PubMed - indexed for MEDLINE]Related articles

    3.

    Cardiac repolarization and the safety of new drugs defined by electrocardiography.

    Morganroth J.

    Clin Pharmacol Ther. 2007 Jan;81(1):108-13.PMID: 17186008 [PubMed - indexed for MEDLINE]Related articles

    4.

    Eletrocardiographic monitoring in COPD patients receiving tiotropium.

    Morganroth J, Golisch W, Kesten S.

    COPD. 2004;1(2):181-90.PMID: 17136986 [PubMed - indexed for MEDLINE]Related articles

    5.

    Evaluation of the effect on cardiac repolarization (QTc interval) of oncologic drugs.

    Morganroth J.

    Ernst Schering Res Found Workshop. 2007;(59):171-84. Review.PMID: 17117723 [PubMed - indexed for MEDLINE]Related articles

    6.

    Telavancin versus standard therapy for treatment of complicated skin and skin structure infections caused by gram-positive bacteria: FAST 2 study.

    Stryjewski ME, Chu VH, O'Riordan WD, Warren BL, Dunbar LM, Young DM, Vallée M, Fowler VG Jr, Morganroth J, Barriere SL, Kitt MM, Corey GR; FAST 2 Investigator Group.

    Antimicrob Agents Chemother. 2006 Mar;50(3):862-7.PMID: 16495243 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    A randomized trial comparing the cardiac rhythm safety of moxifloxacin vs levofloxacin in elderly patients hospitalized with community-acquired pneumonia.

    Morganroth J, Dimarco JP, Anzueto A, Niederman MS, Choudhri S; CAPRIE Study Group.

    Chest. 2005 Nov;128(5):3398-406.PMID: 16304291 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Effects of a new antibacterial, telavancin, on cardiac repolarization (QTc interval duration) in healthy subjects.

    Barriere S, Genter F, Spencer E, Kitt M, Hoelscher D, Morganroth J.

    J Clin Pharmacol. 2004 Jul;44(7):689-95.PMID: 15199073 [PubMed - indexed for MEDLINE]Related articles

    9.

    Evaluation of vardenafil and sildenafil on cardiac repolarization.

    Morganroth J, Ilson BE, Shaddinger BC, Dabiri GA, Patel BR, Boyle DA, Sethuraman VS, Montague TH.

    Am J Cardiol. 2004 Jun 1;93(11):1378-83, A6.PMID: 15165918 [PubMed - indexed for MEDLINE]Related articles

    10.

    A definitive or thorough phase 1 QT ECG trial as a requirement for drug safety assessment.

    Morganroth J.

    J Electrocardiol. 2004 Jan;37(1):25-9. Review.PMID: 15132366 [PubMed - indexed for MEDLINE]Related articles

    11.

    Drug-induced cardiac toxicity: emphasizing the role of electrocardiography in clinical research and drug development.

    Gussak I, Litwin J, Kleiman R, Grisanti S, Morganroth J.

    J Electrocardiol. 2004 Jan;37(1):19-24. Review.PMID: 15132365 [PubMed - indexed for MEDLINE]Related articles

    12.

    Clinical experience with moxifloxacin in patients with respiratory tract infections.

    Faich GA, Morganroth J, Whitehouse AB, Brar JS, Arcuri P, Kowalsky SF, Haverstock DC, Celesk RA, Church DA.

    Ann Pharmacother. 2004 May;38(5):749-54. Epub 2004 Mar 16.PMID: 15026565 [PubMed - indexed for MEDLINE]Related articles

    13.

    Electrocardiographic identification of drug-induced QT prolongation: assessment by different recording and measurement methods.

    Sarapa N, Morganroth J, Couderc JP, Francom SF, Darpo B, Fleishaker JC, McEnroe JD, Chen WT, Zareba W, Moss AJ.

    Ann Noninvasive Electrocardiol. 2004 Jan;9(1):48-57.PMID: 14731216 [PubMed - indexed for MEDLINE]Related articles

    14.

    Identification of sotalol-induced changes in repolarization with T wave area-based repolarization duration parameters.

    Couderc JP, Zareba W, Moss AJ, Sarapa N, Morganroth J, Darpo B.

    J Electrocardiol. 2003;36 Suppl:115-20.PMID: 14716611 [PubMed - indexed for MEDLINE]Related articles

    15.

    Tegaserod, a 5-hydroxytryptamine type 4 receptor partial agonist, is devoid of electrocardiographic effects.

    Morganroth J, Rüegg PC, Dunger-Baldauf C, Appel-Dingemanse S, Bliesath H, Lefkowitz M.

    Am J Gastroenterol. 2002 Sep;97(9):2321-7.PMID: 12358251 [PubMed - indexed for MEDLINE]Related articles

    16.

    Electrocardiographic effects of rivastigmine.

    Morganroth J, Graham S, Hartman R, Anand R.

    J Clin Pharmacol. 2002 May;42(5):558-68.PMID: 12017350 [PubMed - indexed for MEDLINE]Related articles

    17.

    The pharmacokinetics and safety of single escalating oral doses of eletriptan.

    Shah AK, Harris SC, Greenhalgh C, Morganroth J.

    J Clin Pharmacol. 2002 May;42(5):520-7.PMID: 12017346 [PubMed - indexed for MEDLINE]Related articles

    18.

    Effects of supratherapeutic doses of ebastine and terfenadine on the QT interval.

    Gillen MS, Miller B, Chaikin P, Morganroth J.

    Br J Clin Pharmacol. 2001 Aug;52(2):201-4. Erratum in: Br J Clin Pharmacol 2001 Sep;52(3):343. PMID: 11488779 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Cardiac effects of ebastine and other antihistamines in humans.

    Moss AJ, Morganroth J.

    Drug Saf. 1999;21 Suppl 1:69-80; discussion 81-7. Review. Erratum in: Drug Saf 2000 Mar;22(3):214. PMID: 10597870 [PubMed - indexed for MEDLINE]Related articles

    20.

    The effect of terfenadine on the cardiac pharmacodynamics of sparfloxacin.

    Morganroth J, Hunt T, Dorr MB, Magner D, Talbot GH.

    Clin Ther. 1999 Sep;21(9):1514-24.PMID: 10509846 [PubMed - indexed for MEDLINE]Related articles

    21.

    The cardiac pharmacodynamics of therapeutic doses of sparfloxacin.

    Morganroth J, Hunt T, Dorr MB, Magner D, Talbot GH.

    Clin Ther. 1999 Jul;21(7):1171-81.PMID: 10463515 [PubMed - indexed for MEDLINE]Related articles

    22.

    A review of the cardiac systemic side-effects of antihistamines: ebastine.

    Moss AJ, Chaikin P, Garcia JD, Gillen M, Roberts DJ, Morganroth J.

    Clin Exp Allergy. 1999 Jul;29 Suppl 3:200-5. Review.PMID: 10444238 [PubMed - indexed for MEDLINE]Related articles

    23.

    Effect of single ascending, supratherapeutic doses of sparfloxacin on cardiac repolarization (QTc interval).

    Morganroth J, Talbot GH, Dorr MB, Johnson RD, Geary W, Magner D.

    Clin Ther. 1999 May;21(5):818-28.PMID: 10397377 [PubMed - indexed for MEDLINE]Related articles

    24.

    Lack of effect of azelastine and ketoconazole coadministration on electrocardiographic parameters in healthy volunteers.

    Morganroth J, Lyness WH, Perhach JL, Mather GG, Harr JE, Trager WF, Levy RH, Rosenberg A.

    J Clin Pharmacol. 1997 Nov;37(11):1065-72.PMID: 9506001 [PubMed - indexed for MEDLINE]Related articles

    25.

    Oral bropirimine immunotherapy of carcinoma in situ of the bladder: results of a phase II trial.

    Sarosdy MF, Lowe BA, Schellhammer PF, Lamm DL, Graham SD Jr, Grossman HB, See WA, Peabody JO, Moon TD, Flanigan RC, Crawford ED, Morganroth J.

    Urology. 1996 Jul;48(1):21-7.PMID: 8693646 [PubMed - indexed for MEDLINE]Related articles

    26.

    Systemic concentrations of salbutamol and HFA-134a after inhalation of salbutamol sulfate in a chlorofluorocarbon-free system.

    Harrison LI, Cline A, Wells TM, Jacobson JP, Cooper KM, Chang SF, Nelson JR, Ekholm BP, Morganroth J.

    Ther Drug Monit. 1996 Jun;18(3):240-4.PMID: 8738762 [PubMed - indexed for MEDLINE]Related articles

    27.

    Overview of electrocardiographic and cardiovascular safety data for sparfloxacin. Sparfloxacin Safety Group.

    Jaillon P, Morganroth J, Brumpt I, Talbot G.

    J Antimicrob Chemother. 1996 May;37 Suppl A:161-7. Review.PMID: 8737135 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    Dose-response relation between terfenadine (Seldane) and the QTc interval on the scalar electrocardiogram: distinguishing a drug effect from spontaneous variability.

    Pratt CM, Ruberg S, Morganroth J, McNutt B, Woodward J, Harris S, Ruskin J, Moye L.

    Am Heart J. 1996 Mar;131(3):472-80.PMID: 8604626 [PubMed - indexed for MEDLINE]Related articles

    29.

    Prediction of cardiac death in patients with a very low ejection fraction after myocardial infarction: a Cardiac Arrhythmia Suppression Trial (CAST) study.

    Josephson RA, Chahine RA, Morganroth J, Anderson J, Waldo A, Hallstrom A.

    Am Heart J. 1995 Oct;130(4):685-91.PMID: 7572573 [PubMed - indexed for MEDLINE]Related articles

    30.

    Effects of food on the bioequivalence of different verapamil sustained-release formulations.

    Waldman SA, Morganroth J.

    J Clin Pharmacol. 1995 Feb;35(2):163-9.PMID: 7751427 [PubMed - indexed for MEDLINE]Related articles

    31.

    New insights into the definition and meaning of proarrhythmia during initiation of antiarrhythmic drug therapy from the Cardiac Arrhythmia Suppression Trial and its pilot study. The CAST and CAPS Investigators.

    Wyse DG, Morganroth J, Ledingham R, Denes P, Hallstrom A, Mitchell LB, Epstein AE, Woosley RL, Capone R.

    J Am Coll Cardiol. 1994 Apr;23(5):1130-40.PMID: 8144779 [PubMed - indexed for MEDLINE]Related articles

    32.
    33.

    Variability of the QTc interval: impact on defining drug effect and low-frequency cardiac event.

    Morganroth J, Brown AM, Critz S, Crumb WJ, Kunze DL, Lacerda AE, Lopez H.

    Am J Cardiol. 1993 Aug 26;72(6):26B-31B.PMID: 8256752 [PubMed - indexed for MEDLINE]Related articles

    34.

    Relations of QTc prolongation on the electrocardiogram to torsades de pointes: definitions and mechanisms.

    Morganroth J.

    Am J Cardiol. 1993 Aug 26;72(6):10B-13B. Review.PMID: 8256748 [PubMed - indexed for MEDLINE]Related articles

    35.
    36.

    Use of claims data for determining the appropriateness of ambulatory cardiac monitoring.

    Shulkin DJ, Lieberman J, Morganroth J, Schwartz JS.

    Am J Cardiol. 1993 Mar 15;71(8):749-50. No abstract available. PMID: 8447277 [PubMed - indexed for MEDLINE]Related articles

    37.

    Diagnostic accuracy of seismocardiography compared with electrocardiography for the anatomic and physiologic diagnosis of coronary artery disease during exercise testing.

    Wilson RA, Bamrah VS, Lindsay J Jr, Schwaiger M, Morganroth J.

    Am J Cardiol. 1993 Mar 1;71(7):536-45.PMID: 8438739 [PubMed - indexed for MEDLINE]Related articles

    38.

    Drug-induced early and late proarrhythmia.

    Morganroth J.

    Cardiol Clin. 1992 Aug;10(3):397-401. Review.PMID: 1504971 [PubMed - indexed for MEDLINE]Related articles

    39.

    The relationship of anticoagulation level and complications after successful percutaneous transluminal coronary angioplasty.

    McGarry TF Jr, Gottlieb RS, Morganroth J, Zelenkofske SL, Kasparian H, Duca PR, Lester RM, Kreulen TH.

    Am Heart J. 1992 Jun;123(6):1445-51.PMID: 1595522 [PubMed - indexed for MEDLINE]Related articles

    40.

    Proarrhythmic effects of antiarrhythmic drugs: evolving concepts.

    Morganroth J.

    Am Heart J. 1992 Apr;123(4 Pt 2):1137-9. Review.PMID: 1553883 [PubMed - indexed for MEDLINE]Related articles

    41.

    Early and late proarrhythmia from antiarrhythmic drug therapy.

    Morganroth J.

    Cardiovasc Drugs Ther. 1992 Feb;6(1):11-4.PMID: 1533532 [PubMed - indexed for MEDLINE]Related articles

    42.

    Signal-averaged electrocardiography and ambulatory monitoring.

    Greenberg R, Morganroth J, Zelenkofske S, Greenspon A.

    Cardiovasc Clin. 1992;22(1):47-69. Review. No abstract available. PMID: 1728436 [PubMed - indexed for MEDLINE]Related articles

    43.

    Events in the cardiac arrhythmia suppression trial: baseline predictors of mortality in placebo-treated patients.

    Capone RJ, Pawitan Y, el-Sherif N, Geraci TS, Handshaw K, Morganroth J, Schlant RC, Waldo AL.

    J Am Coll Cardiol. 1991 Nov 15;18(6):1434-8.PMID: 1939943 [PubMed - indexed for MEDLINE]Related articles

    44.

    Quinidine-related mortality in the short-to-medium-term treatment of ventricular arrhythmias. A meta-analysis.

    Morganroth J, Goin JE.

    Circulation. 1991 Nov;84(5):1977-83.PMID: 1834365 [PubMed - indexed for MEDLINE]Related articles

    45.

    A multicenter evaluation of the A&D TM-2420 ambulatory blood pressure recorder.

    White WB, Pickering TG, Morganroth J, James GD, McCabe EJ, Moucha O, Hunter H.

    Am J Hypertens. 1991 Nov;4(11):890-6.PMID: 1789952 [PubMed - indexed for MEDLINE]Related articles

    46.

    Sudden death during ambulatory electrocardiographic monitoring.

    Pepine CJ, Morganroth J, McDonald JT, Gottlieb SO.

    Am J Cardiol. 1991 Sep 15;68(8):785-8. No abstract available. PMID: 1892087 [PubMed - indexed for MEDLINE]Related articles

    47.

    Effect of angiotensin converting enzyme inhibition on the incidence of restenosis after percutaneous transluminal coronary angioplasty.

    Brozovich FV, Morganroth J, Gottlieb NB, Gottlieb RS.

    Cathet Cardiovasc Diagn. 1991 Aug;23(4):263-7.PMID: 1653645 [PubMed - indexed for MEDLINE]Related articles

    48.

    Variability of the QT measurement in healthy men, with implications for selection of an abnormal QT value to predict drug toxicity and proarrhythmia.

    Morganroth J, Brozovich FV, McDonald JT, Jacobs RA.

    Am J Cardiol. 1991 Apr 1;67(8):774-6. No abstract available. PMID: 2006632 [PubMed - indexed for MEDLINE]Related articles

    49.

    Pharmacologic management of ventricular arrhythmias after the cardiac arrhythmia suppression trial.

    Morganroth J, Bigger JT Jr.

    Am J Cardiol. 1990 Jun 15;65(22):1497-503. No abstract available. PMID: 2091621 [PubMed - indexed for MEDLINE]Related articles

    50.

    Determination of antiarrhythmic drug efficacy in the treatment of ventricular arrhythmias.

    Morganroth J.

    Cardiovasc Drugs Ther. 1990 Jun;4(3):669-73. Review.PMID: 2076377 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...